Multicenter Randomized Controlled Trial on the Interest of Intravitreal Injections of Anti-VEGF as Initial and Adjuvant Treatment in Coats Disease
Conditions: Retinal Telangiectasis; Coats Disease Interventions: Drug: Anti-VEGF injections of bevacizumab; Device: Laser Sponsor: Fondation Ophtalmologique Adolphe de Rothschild Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials